Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof on In Vivo properties
Nanoparticle (NP) therapeutics have the potential to significantly alter the in vivo biological properties of the pharmaceutically active agents that they carry. Here we describe the development of a polymeric NP, termed M-NP, comprising poly(d,l-lactic-co-glycolic acid)-block-poly(ethylene glycol)...
Main Authors: | Kulak, Nora (Contributor), Pridgen, Eric M. (Contributor), Farokhzad, Omid C. (Contributor), Lippard, Stephen J. (Contributor), Johnstone, Timothy (Contributor), Langer, Robert S (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Massachusetts Institute of Technology. Department of Chemistry (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Langer, Robert (Contributor) |
Format: | Article |
Language: | English |
Published: |
American Chemical Society (ACS),
2015-02-24T16:24:08Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Mitaplatin, a Potent Fusion of Cisplatin and the Orphan Drug Dichloroacetate
by: Lippard, Stephen J., et al.
Published: (2011) -
The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
by: Johnstone, Timothy, et al.
Published: (2014) -
In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles
by: Chan, Juliana Maria, et al.
Published: (2012) -
Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy
by: Valencia, Pedro M., et al.
Published: (2015) -
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
by: Alexis, Frank, et al.
Published: (2012)